| For: | Peroukides S, Makatsoris T, Koutras A, Tsamandas A, Onyenadum A, Labropoulou-Karatza C, Kalofonos H. Lapatinib-induced hepatitis: A case report. World J Gastroenterol 2011; 17(18): 2349-2352 [PMID: 21633602 DOI: 10.3748/wjg.v17.i18.2349] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i18/2349.htm |
| Number | Citing Articles |
| 1 |
Debra H. Josephs, Danielle S. Fisher, James Spicer, Robert J. Flanagan. Clinical Pharmacokinetics of Tyrosine Kinase Inhibitors. Therapeutic Drug Monitoring 2013; 35(5) doi: 10.1097/FTD.0b013e318292b931
|
| 2 |
F. Alessandrino, S.H. Tirumani, K.M. Krajewski, A.B. Shinagare, J.P. Jagannathan, N.H. Ramaiya, D.N. Di Salvo. Imaging of hepatic toxicity of systemic therapy in a tertiary cancer centre: chemotherapy, haematopoietic stem cell transplantation, molecular targeted therapies, and immune checkpoint inhibitors. Clinical Radiology 2017; 72(7) doi: 10.1016/j.crad.2017.04.003
|
| 3 |
Nelia Hernandez. Hepatotoxicity of New Antitumor Agents. Current Hepatology Reports 2017; 16(4) doi: 10.1007/s11901-017-0381-7
|
| 4 |
Ali Ergüç, Gökay Albayrak, Muhammed Tilahun Muhammed, Fuat Karakuş, Ege Arzuk, Elif İnce-Ergüç.
Exploring the role of quercetin on doxorubicin and lapatinib-mediated cellular and mitochondrial responses using
in vitro
and
in silico
studies
. Journal of Chemotherapy 2026; 38(1) doi: 10.1080/1120009X.2025.2471154
|
| 5 |
Y. Maor, S. Malnick. Liver Injury Induced by Anticancer Chemotherapy and Radiation Therapy. International Journal of Hepatology 2013; 2013 doi: 10.1155/2013/815105
|
| 6 |
Joanna E. Barbara, Faraz Kazmi, Andrew Parkinson, David B. Buckley. Metabolism-Dependent Inhibition of CYP3A4 by Lapatinib: Evidence for Formation of a Metabolic Intermediate Complex with a Nitroso/Oxime Metabolite Formed via a Nitrone Intermediate. Drug Metabolism and Disposition 2013; 41(5) doi: 10.1124/dmd.113.051151
|
| 7 |
Lishan Lin, Cen Xie, Zhiwei Gao, Xiaoyan Chen, Dafang Zhong. Metabolism and Pharmacokinetics of Allitinib in Cancer Patients: The Roles of Cytochrome P450s and Epoxide Hydrolase in its Biotransformation. Drug Metabolism and Disposition 2014; 42(5) doi: 10.1124/dmd.113.056341
|
| 8 |
|
| 9 |
Feiyan Lin, Shuanghu Wang, Yunfang Zhou, Chunmei Wu, Huilong Zou, Peiwu Geng, Qingwei Zhang, Xiuhua Zhang. Pharmacokinetic Interaction Study Combining Lapatinib with Vorinostat in Rats. Pharmacology 2015; 95(3-4) doi: 10.1159/000380954
|
| 10 |
Neil M. Iyengar, Monica N. Fornier, Steven M. Sugarman, Maria Theodoulou, Tiffany A. Troso-Sandoval, Gabriella M. D'Andrea, Pamela R. Drullinsky, Devika Gajria, Shari B. Goldfarb, Elizabeth A. Comen, Diana E. Lake, Shanu Modi, Tiffany A. Traina, Mario E. Lacouture, Melanie F. Chen, Sujata Patil, José Baselga, Larry Norton, Clifford A. Hudis, Chau T. Dang. A Pilot Study of Dose-Dense Paclitaxel With Trastuzumab and Lapatinib for Node-negative HER2-Overexpressed Breast Cancer. Clinical Breast Cancer 2016; 16(2) doi: 10.1016/j.clbc.2015.09.009
|
| 11 |
Zhuo Zhang, Ling Xu, Naishan Qin, Jixin Zhang, Qian Xiang, Qian Liu, Yuanjia Cheng, Yuge Bai, Qianxin Liu, Yinhua Liu, Xuening Duan, Yimin Cui. Case report: Secondary sclerosing cholangitis induced by lapatinib and vinorelbine in a metastasis breast cancer patient. Thoracic Cancer 2021; 12(12) doi: 10.1111/1759-7714.13986
|
| 12 |
Jennifer E. Bissada, Vivian Truong, Arsany A. Abouda, Kahari J. Wines, Rachel D. Crouch, Klarissa D. Jackson. Interindividual Variation in CYP3A Activity Influences Lapatinib Bioactivation. Drug Metabolism and Disposition 2019; 47(11) doi: 10.1124/dmd.119.088823
|
| 13 |
Wimonchat Tangamornsuksan, Chuenjid Kongkaew, C. N. Scholfield, Suphat Subongkot, Manupat Lohitnavy. HLA-DRB1*07:01 and lapatinib-induced hepatotoxicity: a systematic review and meta-analysis. The Pharmacogenomics Journal 2020; 20(1) doi: 10.1038/s41397-019-0092-2
|
| 14 |
JL Woodhead, K Yang, KLR Brouwer, SQ Siler, SH Stahl, JL Ambroso, D Baker, PB Watkins, BA Howell. Mechanistic Modeling Reveals the Critical Knowledge Gaps in Bile Acid–Mediated DILI. CPT: Pharmacometrics & Systems Pharmacology 2014; 3(7) doi: 10.1038/psp.2014.21
|
| 15 |
Melvin J. Rivera, Bryan Do, Jeffrey C. Bryan, Terri Lynn Shigle, Rina Patel. Oncologic Critical Care. 2019; doi: 10.1007/978-3-319-74698-2_21-1
|
| 16 |
. 2013; doi: 10.70675/f5056180z01e7z4582za0dfzbd23f7fb884d
|
| 17 |
Stephanie A. Howard, Michael H. Rosenthal, Jyothi P. Jagannathan, Katherine M. Krajewski, Atul B. Shinagare, Nikhil H. Ramaiya, Sree Harsha Tirumani. Beyond the Vascular Endothelial Growth Factor Axis: Update on Role of Imaging in Nonantiangiogenic Molecular Targeted Therapies in Oncology. American Journal of Roentgenology 2015; 204(5) doi: 10.2214/AJR.14.12876
|
| 18 |
|
| 19 |
Haochen Jiang, Ying Jin, Hao Yan, Zhifei Xu, Bo Yang, Qiaojun He, Peihua Luo. Hepatotoxicity of FDA-approved small molecule kinase inhibitors. Expert Opinion on Drug Safety 2021; 20(3) doi: 10.1080/14740338.2021.1867104
|
| 20 |
Noëmi Johanna Roos, Diell Aliu, Jamal Bouitbir, Stephan Krähenbühl. Lapatinib Activates the Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 Pathway in HepG2 Cells. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00944
|
| 21 |
Camille Houron, Marie Danielou, Olivier Mir, Bernard Fromenty, Gabriel Perlemuter, Cosmin Sebastian Voican. Multikinase inhibitor-induced liver injury in patients with cancer: A review for clinicians. Critical Reviews in Oncology/Hematology 2021; 157 doi: 10.1016/j.critrevonc.2020.103127
|
| 22 |
Paige H. Parrack, Stephen D. Zucker, Lei Zhao. Liver Pathology Related to Onco-Therapeutic Agents. Surgical Pathology Clinics 2023; 16(3) doi: 10.1016/j.path.2023.04.006
|
| 23 |
Jaymin J Kathiriya, Ravi Ramesh Pathak, Eric Clayman, Bin Xue, Vladimir N Uversky, Vrushank Davé. Presence and utility of intrinsically disordered regions in kinases. Molecular BioSystems 2014; 10(11) doi: 10.1039/C4MB00224E
|
| 24 |
Chalermrat Bunchorntavakul, K. Rajender Reddy. Drug Hepatotoxicity. Clinics in Liver Disease 2017; 21(1) doi: 10.1016/j.cld.2016.08.009
|
| 25 |
Victor-Mihai Sacerdoțianu, Costin-Teodor Streba, Ion Rogoveanu, Liliana Streba, Cristin Constantin Vere. Hepatotoxicity. 2022; doi: 10.5772/intechopen.106214
|
| 26 |
Kirsty Wai-Chung Lee, Stephen Lam Chan. Hepatotoxicity of targeted therapy for cancer. Expert Opinion on Drug Metabolism & Toxicology 2016; 12(7) doi: 10.1080/17425255.2016.1190831
|
| 27 |
Melvin J. Rivera, Bryan Do, Jeffrey C. Bryan, Terri Lynn Shigle, Rina Patel. Oncologic Critical Care. 2020; doi: 10.1007/978-3-319-74588-6_21
|